GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Chemfab Alkalis Ltd

Chemfab Alkalis: India Ratings Affirms Bank Loan Facilities at BBB+/Negative

RATING ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 08 Oct 2026, 03:03 PM IST  ·  BSE ID: 3e4327fb-2381-484c-a6ee-cc5a173b8806
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's bank loan rating was affirmed, but the outlook remains negative due to slow business recovery.
🤖 AI Summary
  • India Ratings affirmed Chemfab Alkalis' bank loan facilities at IND BBB+/Negative.
  • Affirmation on INR 1,700 million bank loan facilities by India Ratings and Research.
  • Negative Outlook reflects slower-than-expected recovery in FY26 and 1QFY27 performance.
  • Expectation of meaningful recovery in operating performance in 2HFY27 based on order book.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Bank loan facilities size
1700 INR million
Rating assigned
IND BBB+/Negative/IND A2
🏢 How This Affects the Company
📈
Business Impact
A negative outlook on bank loan facilities signals potential investor caution, though the affirmation provides stability. The company expects a recovery in its pipes business driven by government projects.
💰
Financial Impact
The affirmation on INR 1,700 million bank loan facilities provides continued access to funding. However, the Negative Outlook suggests ongoing pressure on financial performance due to capacity underutilization impacting EBITDA generation.
⚙️
Operational Impact
The company has implemented cost efficiency measures in its chemicals segment and is seeing benefits from membrane electrolyser commissioning. Capacity expansion efforts are facing challenges due to lower-than-expected demand.
⚠️
Risk Impact
The Negative Outlook flags risks associated with the pace of operating performance recovery and its impact on deleveraging and cash flow generation. Liquidity buffers are monitored closely.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders based on this credit rating update.
👤
Who Is Affected
All shareholders are indirectly affected by credit rating changes which can influence lender sentiment and future financing costs.
🔍
Management Signal
Management is focused on achieving operational recovery and leveraging government initiatives for business growth.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
FY27 2HFY27 performance indicators regarding order booking and execution.
Caustic soda prices and profitability in the chemicals segment.
Progress on Jal Jeevan Mission (JJM) project execution and funding.
MEDIUM RISK Negative outlook on ratings due to operating performance challenges and capacity underutilization.
💡 Investor Takeaway
India Ratings affirmed Chemfab Alkalis' INR 1,700 million bank loan facilities at BBB+/Negative, citing expected recovery in 2HFY27, but flagging ongoing weakness in the OPVC pipe segment.
⚖️ Strengths & Concerns

✅ Positives

  • Diversified product mix in chemicals and pipes segments.
  • Cost reduction initiatives in chemicals are supporting EBITDA and cash flow generation.

⚠️ Concerns

  • Prolonged weakness in the oriented polyvinyl chloride (OPVC) pipe business leading to underutilization.
  • Slower-than-expected recovery in consolidated operating performance in FY26 and 1QFY27.
📅 Company Track Record
In March 2026, Chemfab Alkalis' rating was downgraded to INR BBB+/Negative, with net leverage deteriorating to 3.6x and EBITDA falling 38% YoY.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What rating did India Ratings assign to Chemfab Alkalis' bank loan facilities?
India Ratings and Research affirmed the rating for Chemfab Alkalis Limited's bank loan facilities at IND BBB+/Negative.
What is the size of Chemfab Alkalis' bank loan facilities with the affirmed rating?
The affirmed rating applies to Chemfab Alkalis Limited's bank loan facilities amounting to INR 1,700 million.
Why is the outlook on Chemfab Alkalis' bank loan facilities negative?
The Negative Outlook reflects slower-than-expected recovery in consolidated operating performance in FY26 and 1QFY27 due to weakness in the OPVC pipe business.
What is Chemfab Alkalis' order book size mentioned in the rating report?
Chemfab Alkalis had an order book of around INR 170 million at the end of September 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.